Event Type
Disclosure
Voluntary
Variant
8-K
Regulation FD Disclosure. On January 28, 2026, Annovis Bio, Inc. (the “Registrant”) will conduct a webinar. A copy of the presentation for the webinar is furnis
Financial Statements and Exhibits Exhibit Number Description 99 Presentation for Webinar on January 28, 2026 104 Cover Page Interactive Data File (embedded with